|
Volumn 74, Issue 2, 2002, Pages 77-80
|
Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
CANCER STAGING;
CASE MANAGEMENT;
FOLLOW UP;
HUMAN;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CANCER;
NEOPLASM RECURRENCE, LOCAL;
ORCHIECTOMY;
PATHOLOGY;
RETROSPECTIVE STUDY;
RISK FACTOR;
SEMINOMA;
SURVIVAL RATE;
TESTICULAR NEOPLASMS;
TREATMENT OUTCOME;
TUMOR INVASION;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CARBOPLATIN;
CASE MANAGEMENT;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FOLLOW-UP STUDIES;
HUMANS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEOPLASMS, MULTIPLE PRIMARY;
ORCHIECTOMY;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SEMINOMA;
SURVIVAL RATE;
TESTICULAR NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 0036614933
PISSN: 11243562
EISSN: None
Source Type: None
DOI: None Document Type: Review |
Times cited : (11)
|
References (71)
|